Brief: Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results, Provides Business Update

CervoMed

14/11/2022 21:46

Nov 14 (Reuters) - Diffusion Pharmaceuticals Inc
 DFFN.O :
    * DIFFUSION PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * DIFFUSION PHARMACEUTICALS INC - ENDED QUARTER WITH $25.9
MILLION
IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
    * DIFFUSION PHARMACEUTICALS-CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES WILL FUND OPERATING EXPENSES, CAPITAL EXPENDITURE
REQUIREMENTS INTO Q1 OF 2024
    * DIFFUSION PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $1.37

Source text for Eikon:  ID:nGNXFsR0Y 
Further company coverage:  DFFN.O 
 ((Reuters.Briefs@thomsonreuters.com;))